論文及期刊發表

  • 曾亮維、呂易芩、黃澤宏、李傳耀.內經脈診探討──以太素〈陰陽大論〉一段經文為例. (2024).中醫藥雜誌.第三十五卷第一期.16-33.
  • 曾亮維、陳淼和、黃澤宏.吳遷本. (2023).《金匱要略方》附方之研究.台灣中醫臨床醫學雜誌.29卷1期.12-35.
  • 曾亮維、呂易芩、楊晉瑋、陳育群、陳星諭. (2023). 人參在消化系統疾病的網絡藥理學：健保資料庫的應用.中醫藥雜誌.第三十四卷第一期.77-94.
  • Lee, Y. C., Chang, Y. C., Tseng, L. W., Lin, W. N., Lu, C. T., Lee, L. A., Fang, T. J., Cheng, W. N., & Li, H. Y. (2024). Continuous Positive Airway Pressure Treatment and Hypertensive Adverse Outcomes in Pregnancy: A Systematic Review and Meta-Analysis. JAMA Netw Open, 7(8), e2427557.
  • Lu, Y. C., Tseng, L. W., Wu, C. E., Yang, C. W., Yang, T. H., & Chen, H. Y. (2024). Can Chinese herbal medicine offer feasible solutions for newly diagnosed esophageal cancer patients with malnutrition? a multi-institutional real-world study. Front Pharmacol, 15, 1364318.
  • Yu, H. W., Kuan, C. H., Tseng, L. W., Chen, H. Y., Tsai, M. Y., & Chen, Y. S. (2024). Investigation of the Correlation between Enterovirus Infection and the Climate Factor Complex Including the Ping-Year Factor and El Niño-Southern Oscillation in Taiwan. Viruses, 16(3).
  • Lu, Y. C., Tseng, L. W., Huang, Y. C., Yang, C. W., Chen, Y. C., & Chen, H. Y. (2022). The Potential Complementary Role of Using Chinese Herbal Medicine with Western Medicine in Treating COVID-19 Patients: Pharmacology Network Analysis. Pharmaceuticals (Basel), 15(7).
  • Tseng, L. W., Chang, J. W., & Wu, C. E. (2022). Safety of Tepotinib Challenge after Capmatinib-Induced Pneumonitis in a Patient with Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation: A Case Report. Int J Mol Sci, 23(19).
返回頂端